RESUMO
Objective:To explore the effect of standardized nutrition therapy and nursing in patients with colorectal cancer.Methods:From June 2017 to June 2019, 70 patients with colorectal cancer were selected. They were divided into control group ( n=35) and observation group ( n=35) by random digital table method. The control group was given routine nutrition treatment and nursing, while the observation group was given standardized nutrition treatment plan and nursing. The clinical indexes, nutritional indexes and complications of the two groups were compared, and the immune function before and after operation was compared. Results:The recovery time of bowel sounds, anal exhaust time, defecation time and hospitalization time in the observation group were (3.62±0.64) h, (36.78±11.25) h, (69.74±20.12) h, (15.81±3.57) h, respectively. The control group were (4.08±0.92) h, (44.96±13.83) h, (92.76±19.86) h, (18.83±4.56) h, the difference was statistically significant ( t values were 2.43-4.82, P<0.05 or 0.01). After 7d, the body mass, prealbumin, hemoglobin and serum albumin in observation group were (52.13±5.17) kg, (197.63±39.72) mg/L, (109.74±11.25) g/L, (41.85±5.67) g/L, respectively. The control group were (49.34±4.82) kg, (168.73±32.47) mg/L, (104.06±7.93) g/L, (37.92±4.53), respectively. The difference was statistically significant ( t values were 2.34-3.33, P<0.05 or 0.01). The IgA, IgG, IgM, CD4, CD4/CD8 in the observation group (1.93±0.54) g/L, (11.47±2.35) g/L, (0.96±0.21) g/L, (40.32±5.22)%, 1.68±0.38, the control group were (1.65±0.35) g/L, (9.81±1.69) g/L, (0.81±0.17) g/L, (37.81±4.45)%, 1.49±0.33,The difference was statistically significant ( t values were 2.16-3.39, P<0.05 or 0.01). Conclusions:Standardized nutrition treatment process and nursing can improve the prognosis of colorectal cancer patients, promote the recovery of gastrointestinal function, improve the nutritional status of the body, enhance the immune function of the body.
RESUMO
With in-depth studies on the etiology and pathogenesis, pathological viscera and bowels, and rule of disease progression of primary liver cancer in recent years, some clinical and experimental results have been achieved for the treatment of primary liver cancer with traditional Chinese medicine, such as treatment based on syndrome differentiation and disease differentiation, compound prescriptions and monomers of Chinese herbs, oral administration of drugs/acupuncture and moxibustion/external application, and prevention before disease onset and prevention of recurrence, which reflects the rich methodological connotations of traditional Chinese medicine and lays a foundation for constructing a new diagnostic and therapeutic mode for liver cancer based on integrated traditional Chinese and Western medicine therapy.